The Effects of 4-Methylethcathinone on Conditioned Place Preference, Locomotor Sensitization, and Anxiety-Like Behavior: A Comparison with Methamphetamine. 2016

Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
Drug Intelligence and Forensic Center, Ministry of Public Security, Beijing, PR China (Ms Xu, Mr Bai, Ms Xu, Ms Liu); National Institute on Drug Dependence, Peking University, Beijing, PR China (Mr Qiu, Mr Zhang, and Dr Shen); Institute of Neurosciences, Guangzhou Medical University, Guangzhou, Guangdong, PR China (Mr Zhang); The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC Australia (Dr Kim).

BACKGROUND 4-Methylethcathinone is a drug that belongs to the second generation of synthetic cathinones, and recently it has been ranked among the most popular "legal highs". Although it has similar in vitro neurochemical actions to other drugs such as cocaine, the behavioral effects of 4-methylethcathinone remain to be determined. METHODS The addictive potential and locomotor potentiation by 4-methylethcathinone were investigated in rats using the conditioned place preference and sensitization paradigm. Methamphetamine was used as a positive control. Because synthetic cathinones can have psychological effects, we also examined anxiety-like behavior using the elevated plus maze. RESULTS A conditioning dose of 10 mg/kg 4-methylethcathinone was able to induce conditioned place preference and reinstatement (following 2 weeks of withdrawal). Acute or repeated injections of 4-methylethcathinone at 3 or 10mg/kg failed to alter locomotor activity. At 30 mg/kg, however, acute 4-methylethcathinone increased locomotor activity compared with saline, while chronic 4-methylethcathinone induced a delayed and attenuated sensitization compared with methamphetamine. Additionally, repeated daily injections of 4-methylethcathinone (30 mg/kg) reduced, whereas methamphetamine increased time spent by rats in the open arm of an elevated plus maze compared with saline injections. Interestingly, a 2-week withdrawal period following chronic injections of 4-methylethcathinone or methamphetamine increased time spent in the open arm in all rats. CONCLUSIONS The rewarding properties of 4-methylethcathinone were found to be dissociated from its effects on locomotor activity. Additionally, chronic 4-methylethcathinone use may trigger abnormal anxious behaviors. These behavioral effects caused by 4-methylethcathinone appear to last even after a withdrawal period.

UI MeSH Term Description Entries
D008297 Male Males
D008694 Methamphetamine A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed. Deoxyephedrine,Desoxyephedrine,Desoxyn,Madrine,Metamfetamine,Methamphetamine Hydrochloride,Methylamphetamine,N-Methylamphetamine,Hydrochloride, Methamphetamine,N Methylamphetamine
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D011427 Propiophenones Propiophenone (ethyl phenyl ketone, structural formula C6H5COCH2CH3) and its derivatives. They are commonly used in perfumes and pharmaceuticals.
D002491 Central Nervous System Agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252) Central Nervous System Drugs
D003213 Conditioning, Psychological Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response. Conditioning, Psychology,Psychological Conditioning,Social Learning Theory,Social Learning Theories,Theory, Social Learning
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties

Related Publications

Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
January 2022, Frontiers in molecular neuroscience,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
January 2014, Evidence-based complementary and alternative medicine : eCAM,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
December 2014, Alcoholism, clinical and experimental research,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
June 2000, Pharmacology, biochemistry, and behavior,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
August 1996, Pharmacology, biochemistry, and behavior,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
October 2006, Archives of pharmacal research,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
May 2004, Pharmacology, biochemistry, and behavior,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
July 2014, Behavioural brain research,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
September 1994, Pharmacology, biochemistry, and behavior,
Peng Xu, and Yi Qiu, and Yizhi Zhang, and Yanping Βai, and Pengfei Xu, and Yuan Liu, and Jee Hyun Kim, and Hao-wei Shen
March 2012, Neuropharmacology,
Copied contents to your clipboard!